FDA
-
-
-
-
-
-
-
Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
WAVE Life Sciences (WVE) Announces Positive Data from FORWARD-53 Clinical Trial in DMD
-
-
-
-
-
-
-
Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Pre-Open Movers 12/16: (AXSM) (INFN) (BMRN) Higher (WVE) (PCG) (BA) Lower (more...)
-
-
-
-
-
-
-
Wave Life Sciences Appoints Mark Baldry as Chief Commercial Officer
-
-
-
-
-
-
-
Wave Life Sciences to Present at Parent Project Muscular Dystrophy 2019 Annual Conference
-
-
-
-
-
-
-
Wave Life Sciences to Present Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design at the Muscular Dystrophy Association Clinical and Scientific Conference
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

